Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
1 Dec 2025
WELSH Tool Detects Severe Pregnancy Anaemia Accurately
WELSH pictorial tool correlates strongly with haemoglobin changes in severe pregnancy anaemia.
1 Dec 2025
Experimental mRNA Therapy Targets Multidrug-Resistant Infections
Novel mRNA peptibody therapy reduces bacterial load and inflammation in preclinical MDR pneumonia models, offering a new approach to antibiotic resistance.
1 Dec 2025
Stage IIC Melanoma Patients Show Worse Survival Than Stage IIIA
Swedish study shows patients with stage IIC melanoma have poorer survival than stage IIIA, highlighting need for closer follow-up and treatment.
December 2025
EMJ Microbiology & Infectious Diseases 6 [Supplement 4] 2025
Want to know what’s shaping the future of HIV care in Europe? Our Supplement Journal covering the 20th EACS Conference is here…
1
Mins
1 Dec 2025
Characterisation of Natural Killer Cell Subsets in a Case of Sustained HIV Remission
Natural killer (NK) cells are increasingly studied in HIV cure research as certain subsets have been linked to natural HIV control…
12
Mins
1 Dec 2025
Review of the 20
th
European AIDS Clinical Society (EACS) Conference
THE 20th European AIDS Clinical Society (EACS) Conference opened its doors in Paris, France, from 15th–18th October 2025…
4
Mins
1 Dec 2025
Five Years to 2030: Europe’s Race to End the AIDS Epidemic
WITH ONLY 5 years remaining to meet the Joint United Nations Programme on HIV/AIDS (UNAIDS) 2030 target of ending AIDS as a public…
1
Mins
1 Dec 2025
PrEP Continuity: Insights from Nigeria’s 2024 National Rollout
Despite the rapid expansion of oral pre-exposure prophylaxis (PrEP) services in Nigeria, programmatic data continue to highlight critical…
30 Nov 2025
Heart Failure Has Doubled in Numbers Since 1988
USA adults living with heart failure have more than doubled since 1988, with risk factors shifting from hypertension and cholesterol to obesity, diabetes, and kidney disease.
30 Nov 2025
Upper Tract Versus Bladder Cancer: Outcomes of Sequential Therapy
Sequential therapy shows poorer outcomes in upper tract urothelial carcinoma than bladder cancer, highlighting the need for more effective first-line treatments.
←
1
2
3
4
5
6
7
8
9
10
…
1,309
1,310
1,311
→
We’ve noticed you’re accessing
from
North/South America.
View
View